Procter & Gamble CO 8-K filings

The Procter & Gamble Company announced its fiscal year 2026 results, showing modest organic sales growth and core EPS in line with expectations, while providing guidance for fiscal year 2027.

The Procter & Gamble Company announces leadership changes with Shailesh Jejurikar appointed Chairman and Jon Moeller retiring.

The Procter & Gamble Company announced its fourth quarter and fiscal year 2026 results, reporting modest sales growth and earnings per share increases, while outlining expectations for continued progress in fiscal year 2027.

The Procter & Gamble Company announced its Board of Directors has declared a quarterly dividend of $1.0885 per share on its Common Stock and preferred stock, payable on or after August 17, 2026.

The Procter & Gamble Company announced its third quarter fiscal year 2026 results, showing sequential improvement in organic sales and core earnings per share.

The Procter & Gamble Company announced its fiscal year 2026 third quarter results, reporting a 7% increase in net sales to $21.2 billion and a 6% rise in diluted EPS to $1.63.

The Procter & Gamble Company announced an increased quarterly dividend of $1.0885 per share, marking a 3% rise and continuing a 70-year streak of dividend increases.

Procter & Gamble reported flat organic sales and in-line core earnings per share for Q2 FY2026, impacted by base period dynamics and market trends.

Procter & Gamble reported a one percent increase in net sales to $22.2 billion for Q2 FY26, while diluted EPS decreased five percent to $1.78 primarily due to restructuring charges.

Procter & Gamble's Board of Directors declared a quarterly dividend of $1.0568 per share, payable on or after February 17, 2026.

Procter & Gamble's Chief Executive Officer of Health Care, Jennifer Davis, will retire effective June 30, 2026, after over three decades of service.

The Procter & Gamble Company announced the closing of an underwritten public offering of $258.9 million in Floating Rate Notes due November 4, 2075.

Procter & Gamble successfully completed a $2.25 billion public offering of notes with maturities ranging from 2032 to 2045.

Procter & Gamble announced its first quarter fiscal year 2026 results, with organic sales growing 2% driven by pricing and mix, and core EPS increasing 3%.

Procter & Gamble reported first quarter fiscal year 2026 net sales of $22.4 billion, a 3% increase, with diluted EPS rising 21% to $1.95.

Procter & Gamble shareholders approved the 2025 Stock and Incentive Compensation Plan and re-elected all directors at the Annual Meeting.

Procter & Gamble announced a quarterly dividend of $1.0568 per share and the election of all 14 director nominees at its Annual Meeting of Shareholders.

Procter & Gamble's Chief Executive Officer of Beauty, Alexandra Keith, announced her retirement effective February 20, 2026, after 36 years of service.

Procter & Gamble delivered organic sales growth and core EPS increases in Fiscal Year 2025, driven by strategic execution despite challenging global economic conditions, and provided a cautious outlook for Fiscal Year 2026.

Procter & Gamble announced strong fourth quarter and fiscal year 2025 results, driven by organic sales growth and increased earnings per share, while also detailing a new portfolio and productivity plan and providing fiscal year 2026 guidance.

Procter & Gamble names Shailesh Jejurikar as the next CEO, effective January 1, 2026, with Jon Moeller transitioning to Executive Chairman.

The Procter & Gamble Company announced a quarterly dividend of $1.0568 per share, continuing its long-standing commitment to shareholder returns with 135 consecutive years of dividend payments and 69 consecutive years of increases.

The Procter & Gamble Company announced the appointment of Craig Arnold, former Chairman and CEO of Eaton Corporation, to its Board of Directors, effective June 9, 2025, bringing extensive global leadership and innovation experience.

The Procter & Gamble Company announced a comprehensive two-year non-core restructuring program at the Deutsche Bank dbAccess Global Consumer Conference, aiming to optimize its portfolio, supply chain, and organization design, which includes reducing up to 7,000 non-manufacturing roles and incurring charges of $1.0 to $1.6 billion.

Procter & Gamble successfully closed a public offering of $1.25 billion in notes, split between 4.050% notes due 2030 and 4.600% notes due 2035.

Procter & Gamble's third-quarter results for fiscal year 2025 were affected by consumer and retailer volatility, with organic sales up 1% driven by pricing, and the company maintaining its full-year guidance.

Procter & Gamble reports a mixed Q3 FY25 with a decrease in net sales but an increase in organic sales, updating its fiscal year sales and EPS guidance while maintaining cash return guidance.

Procter & Gamble's Board of Directors has declared an increased quarterly dividend of $1.0568 per share, marking the 69th consecutive year of dividend increases.

Procter & Gamble reported a 3% organic sales growth in the second quarter of fiscal year 2025, allowing them to maintain their full-year guidance.

Procter & Gamble reported a 2% increase in net sales and a 3% increase in organic sales for the second quarter of fiscal year 2025, while maintaining its full-year guidance.